Related Experiment Video
Updated: Feb 11, 2026
Author Spotlight: Refining Xenopus laevis Marking Techniques for Biomedical Studies
Published on: June 28, 2024
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis
G Sabatakos1, N A Sims, J Chen
1Departments of Cell Biology and Orthopaedics, Yale University School of Medicine SHM IE-55, 333 Cedar St, New Haven, Connecticut 06520-8044, USA.
Abstract:
Members of the AP-1 family of transcription factors participate in the regulation of bone cell proliferation and differentiation. We report here a potent AP-1-related regulator of osteoblast function: DeltaFosB, a naturally occurring truncated form of FosB that arises from alternative splicing of the fosB transcript and is expressed in osteoblasts. Overexpression of DeltaFosB in transgenic mice leads to increased bone formation throughout the skeleton and a continuous post-developmental increase in bone mass, leading to osteosclerosis. In contrast, DeltaFosB inhibits adipogenesis both in vivo and in vitro, and downregulates the expression of early markers of adipocyte differentiation. Because osteoblasts and adipocytes are thought to share a common precursor, it is concluded that DeltaFosB transcriptionally regulates osteoblastogenesis, possibly at the expense of adipogenesis.
Insights
DeltaFosB, a transcription factor, significantly boosts bone formation and mass in mice. It also inhibits fat cell development, suggesting a role in directing stem cells toward bone cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Bone Biology
Background:
- Transcription factors of the Activator Protein-1 (AP-1) family regulate bone cell proliferation and differentiation.
- The FosB gene produces various protein isoforms through alternative splicing.
Purpose of the Study:
- To investigate the role of DeltaFosB, an AP-1-related transcription factor, in regulating osteoblast function and bone mass.
- To determine the effect of DeltaFosB on adipogenesis, the development of fat cells.
Main Methods:
- Overexpression of DeltaFosB in transgenic mice.
- In vivo and in vitro studies of adipogenesis.
- Analysis of osteoblast and adipocyte differentiation markers.
Main Results:
- Overexpression of DeltaFosB in mice resulted in increased bone formation and a continuous rise in bone mass, leading to osteosclerosis.
- DeltaFosB inhibited adipogenesis both in vivo and in vitro.
- The expression of early adipocyte differentiation markers was downregulated by DeltaFosB.
Conclusions:
- DeltaFosB is a potent regulator of osteoblast function and bone mass.
- DeltaFosB plays a role in directing the differentiation of common precursor cells towards osteoblasts, potentially inhibiting adipogenesis.
- These findings highlight DeltaFosB's potential as a therapeutic target for bone-related disorders.
More Related Videos
Related Concept Videos
04:18Methods for Tattooing Xenopus laevis with a Rotary Tattoo Machine
08:07A Two-Step Pyrolysis-Gas Chromatography Method with Mass Spectrometric Detection for Identification of Tattoo Ink Ingredients and Counterfeit Products
07:42Inkjet Printing All Inorganic Halide Perovskite Inks for Photovoltaic Applications
09:58Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems
06:37Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
10:49Planar and Three-Dimensional Printing of Conductive Inks